Usted buscó: platseebokontrolliga (Estonio - Inglés)

platseebokontrolliga uuringud
placebo-controlled studies

kõrvaltoimed platseebokontrolliga uuringutes
undesirable effects in placebo-controlled trials

24-nädalane platseebokontrolliga uuring
24-week placebo-controlled study

platseebokontrolliga uuringute olulisemate efektiivsustulemuste kokkuvõte
summary of key efficacy results from placebo-controlled studies

ravivastuse efektiivsus platseebokontrolliga aksiaalse spa uuringus
efficacy response in placebo-controlled axial spa study

neerupuudulikkusega patsiendid, platseebokontrolliga andmed 52. nädalal
patients with renal impairment, 52 week placebo controlled data

neli uuringut olid topeltpimemeetodil platseebokontrolliga ja üks uuring gi
if the haemoglobin exceeds 12 g/ dl (7.5 mmol/ l), a dose reduction should be considered.

aripiprasooli uuriti ka platseebokontrolliga pikaajalises ravitoime kestvusuuringus.
aripiprazole was also studied in a placebo-controlled, long-term maintenance trial.

platseebokontrolliga uuringus osalenud anküloseeriva spondüliidiga patsientide ravivastused
responses of patients with ankylosing spondylitis in a placebo-controlled trial

disain: randomiseeritud, globaalne mitmekeskuseline, topeltpime, platseebokontrolliga
design: randomised, global multicentre, double-blind, regimen-controlled

neli uuringut olid topeltpimemeetodil platseebokontrolliga ja üks uuring oli avatud.
survival and tumour progression have been examined in five large controlled studies involving a total of 2833 patients, of which four were double-blind placebo-controlled studies and one was an open- label study.

acr vastused platseebokontrolliga uuringutes (patsientide protsent) a vastus
acr responses in placebo-controlled trials

efektiivsuse tõendamiseks tehti kaks randomiseeritud topeltpimedat mitmekeskuselist platseebokontrolliga uuringut.
two randomized, double-blind, multi-centre, placebo-controlled trials were conducted to demonstrate efficacy.

esinemissageduste arvutamisel on lähtutud 17 platseebokontrolliga topeltpimeda kliinilise uuringu koondanalüüsist.
frequencies are calculated based on the integrated analysis of 17 double-blind placebo-controlled clinical studies.

2 platseebokontrolliga kliinilises uuringus raviti eltrombopaagiga 171 kroonilise itp-ga last.
in 2 controlled clinical studies, 171 chronic paediatric itp patients were treated with eltrombopag.

kõrvaltoimed pärinevad seitsme randomiseeritud, topelt- pimemeetodil teostatud, platseebokontrolliga il
do not freeze. lp

96 tabel 3 acr vastused platseebokontrolliga uuringutes (patsientide protsent) a vastus
table 3 acr responses in placebo-controlled trials (percent of patients)

esialgse 6-kuulise platseebokontrolliga perioodi kestel ei täheldatud kliiniliselt olulisi erinevusi.
no clinically significant differences were observed during the initial 6-month placebo-controlled period.

dekompenseeritud maksahaigusega patsientide ravikogemus: dekompenseeritud maksahaigusega patsientidel ei ole platseebokontrolliga uuringuid läbi viidud.
9 experience in patients with decompensated liver disease: placebo controlled studies have been regarded as inappropriate in patients with decompensated liver disease, and have not been undertaken.

4 ravifaasist: üleminek, suukaudne stabiliseerimine, abilify maintena stabiliseerimine ja topeltpime platseebokontrolliga faas.
4 treatment phases: conversion, oral stabilisation, abilify maintena stabilisation, and double-blind placebo-controlled.